# Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab

> **NCT02414984** · — · TERMINATED · sponsor: **Janssen-Cilag, S.A.** · enrollment: 37 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Golimumab

## Key facts

- **NCT ID:** NCT02414984
- **Lead sponsor:** Janssen-Cilag, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Insufficient enrollment (Terminated due to lack of patient recruitment)
- **Last updated:** 2017-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02414984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02414984, "Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02414984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*